Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

In 2022, the American Nurses Credentialing Center unveiled the Magnet with Distinction program to recognize the world’s highest performing Magnet organizations. Since then, 68 hospitals in the U.S.

Bosses are stronger NPC opponents that give you powerful buffs in Fortnite Chapter 7 Season 1. In past seasons, bosses were known to spawn in a singular location, but now, their spawns are ...

Fortnite Chapter 7 Season 1, also known as Pacific Break, will launch on Saturday, Nov. 29 with a Hollywood and U.S. theme. Expect to see iconic characters from hit movies like The Bride from Kill ...

What started as a normal magnet fishing trip took a sharp turn when the magnet latched onto something heavy—something wrapped tight. As we pulled it in, a waterlogged mystery bag surfaced, and no one ...

Scientists are learning how the brain knows what’s happening throughout the body, and how that process might go awry in some psychiatric disorders. By Carl Zimmer Last year, Ardem Patapoutian got a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Arlington biotech Kala Bio has ...

Partnership leverages Manifold's AI-guided direct-to-vivo platform for Roche to create multiple novel brain-targeted therapeutic products Collaboration to utilize Manifold’s mDesign direct-to-vivo ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new Cambridge biotech company ...

The Minnesota Department of Employment and Economic Development gives Niron Magnetics a $10 million grant. The company is building a 190,000-square-foot facility in Sartell to produce rare-earth-free ...

First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...